ArticleKidney international reports2024

An Initial Low-Dose Etelcalcetide Dosing Strategy in Hemodialysis Patients With Moderate Secondary Hyperparathyroidism is Effective and Cost-Saving.

Andrea Carta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.